4//SEC Filing
Burnett Katy 4
Accession 0001562180-21-001276
CIK 0001293971other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 5:22 PM ET
Size
12.3 KB
Accession
0001562180-21-001276
Insider Transaction Report
Form 4
Burnett Katy
Principal Accounting Officer
Transactions
- Award
Common Stock
2021-02-16+2,000→ 3,188 total - Award
Common Stock
2021-02-16+1,427→ 4,615 total - Sale
Common Stock
2021-02-17$28.16/sh−518$14,588→ 4,097 total
Footnotes (4)
- [F1]Restricted stock unit awards vest over a four-year period at the rate of 25% on 01/04/2022, 25% on 01/04/2023, 25% on 01/04/2024, and 25% on 01/04/2025.
- [F2]Immediately vested restricted stock unit reflecting the equity portion of the reporting person's 2020 performance compensation.
- [F3]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- [F4]The range in prices for the transaction reported on this line was $27.97 to $28.54. The average weighted price was $28.1613. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Issuer
bluebird bio, Inc.
CIK 0001293971
Entity typeother
Related Parties
1- filerCIK 0001822349
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 5:22 PM ET
- Size
- 12.3 KB